GlassScriptPrepare for your visit
Michelle M Meade
Family · Bristol, TN · NPI 1790136489
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$1,068.03
in general payments reported to CMS, 2019-2025 · $281 in 2025
The $281 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Who reported paying
General payments only, top 6 by amount.
- Atricure, INC. $457.17
- Abbott Laboratories $149.52
- Astrazeneca Pharmaceuticals LP $70.57
- Daiichi Sankyo INC. $53.77
- Getinge USA Sales, LLC $52.73
- Amgen INC. $49.88
Drugs and devices associated with these payments
Atriclip Laa Exclusion System Atricure Cryoice Cryosphere Cryoablation System Synergy Ablation System Thoratec Heartmate 3 Lvas Implant Kit Epi-Sense Guided Coagulation System With Visitrax Epi-Ease Epicardial Access System Atricure Cryoice Cryoablation System (Cryo2) Injectafer Inpefa Impella Vasoview Hemopro 2 Zio Xt Patch
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Michelle Meade listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/11001050/michelle-m-meade